logo
Questions? +1 (202) 335-3939 Login
Set Up FREE Account Submit Release
Trusted News Since 1995
A service for pharmaceutical industry professionals · Wednesday, July 9, 2025 · 829,905,557 Articles · 3+ Million Readers
Home  •••  Newswires by Industry  •  Countries  •  U.S. States  •  World Media Directory
Pharmaceutical Industry News  •••  Topics  •  Countries  •  U.S. States

Lung Cancer Drugs News Monitoring

  • Published on Jul 8, 2025

    Advancing Treatment for EGFR Inhibitor–Associated Dermal Toxicities

    The application of a genetically modified Staphylococcus epidermidis bacteria–based ointment may reduce EGFR inhibitor–associated dermal toxicities, according to Jonathan Leventhal, MD. Leventhal, an associate professor of dermatology, director of the …

    Source: Cancer Network - New Jersey - Pending
  • Published on 20:25 GMT

    ZL-1310 Shows Promising Activity in Pretreated R/R ES-SCLC

    The DLL3-targeted antibody-drug conjugate zocilurtatug pelitecan (ZL-1310) demonstrated encouraging anti-tumor activity and low rates of drug withdrawal and high-grade adverse events (AEs) in patients with relapsed or refractory extensive-stage small cell …

    Source: Cancer Network - New Jersey - Pending
  • Published on 17:29 GMT

    Map Shows States With Higher Cancer Rates

    Residents in some parts of the United States are more likely to be diagnosed with cancer than others, according to a new analysis of Centers for Disease Control and Prevention (CDC) data. Personal injury attorneys Phillips Law Firm analyzed the most recent …

    Source: Newsweek - Left-wing
  • Published on Jul 7, 2025

    FDA Clears Oncomine Dx Express Test for Sunvozertinib in EGFR Exon 20+ NSCLC

    The FDA has granted approval to the Oncomine™ Dx Express Test on the Ion Torrent™ Genexus™ Dx Integrated Sequencer as a companion diagnostic for sunvozertinib (Zegfrovy) in patients with EGFR exon 20 insertion-positive non–small cell lung cancer (NSCLC). …

    Source: Targeted Oncology - Pending
  • Published on Jul 7, 2025

    FDA OKs NGS Test for Tumor Profiling and as CDx for Sunvozertinib in NSCLC

    The FDA has approved the in vitro diagnostic (IVD) assay Oncomine Dx Express Test on the Ion Torrent Genexus Dx Integrated Sequencer for use as a companion diagnostic (CDx) for sunvozertinib (Zegfrovy) in patients with non–small cell lung cancer (NSCLC) …

    Source: Cancer Network - New Jersey - Pending
  • Published on Jul 7, 2025

    Insurance Gaps Threaten Cancer Treatment Success

    Although intended to improve outcomes for patients living with 1 of 3 stage IV cancer types—melanoma, non–small cell lung cancer (NSCLC), or renal cell carcinoma (RCC)—immune checkpoint inhibitors (ICIs) may not confer equivalent survival benefits among …

    Source: The American Journal of Managed Care - Neutral
  • Published on Jul 7, 2025

    Survival Disparities Increase for Patients Without Health Insurance Following FDA Approval of Immune Checkpoint ...

    Newswise — ATLANTA, July 7, 2025 — In a new study led by the American Cancer Society (ACS), researchers found that the introduction of immune checkpoint inhibitors (ICIs) following FDA approval was associated with a widening survival disparity between …

    Source: Newswise - Neutral
  • Published on Jul 7, 2025

    FDA Approves Oncomine Dx Express Test for Tumor Profiling and as Companion Diagnostic for Sunvozertinib in NSCLC

    The FDA has approved the Oncomine™ Dx Express Test on the Ion Torrent™ Genexus™ Dx Integrated Sequencer as an in vitro diagnostic assay for use as a companion diagnostic for sunvozertinib (Zegfrovy) in EGFR exon 20 insertion mutation–positive non–small …

    Source: OncLive - Pending
  • Published on 16:46 GMT

    Redefining the Impossible With Genomics

    Genome sequencing isn’t just faster and cheaper than ever before, high-throughput platforms are now delivering insights at a scale and depth unimaginable just a few years ago.  From mapping single-cell dynamics to decoding complex disorders, researchers …

    Source: Technology Networks - Neutral
  • Published on 11:26 GMT

    CAR T – cell therapy: The immune system’s smartest weapon yet

    Our immune system: Nature’s defense mechanism  Our body is capable of self-defense. Whenever we catch an infection, we become normal in the next few days. Many a time this happens without any treatment. The reason being internal immense capacity of the …

    Source: Express Healthcare - Neutral
  • Published on 14:25 GMT

    The Immune System in Cancer: Its Roles and How We Can Harness It

    The immune system is designed to recognize and eliminate cancer cells, but tumors have developed sophisticated strategies to evade immune detection and use immune cells to support their growth and metastasis. Immunotherapy approaches aim to reinvigorate …

    Source: Technology Networks - Neutral
  • Published on 16:07 GMT

    Gilead signs lenacapavir access deal; Arvinas CEO to step down

    Today, a brief rundown of news involving Gilead Sciences and Arvinas, as well as updates from Chugai Pharmaceutical, Recursion Pharmaceuticals and Dizal Pharma that you may have missed. Gilead Sciences on Wednesday said it would supply its HIV prevention …

    Source: BioPharma Dive - Pending
  • Published on 20:24 GMT

    Anti-Angiogenesis Plus ICIs, Chemo Improve Frontline Efficacy in ES-SCLC

    Angiogenesis inhibition, when added to frontline immunochemotherapy, improved efficacy outcomes, including progression-free survival (PFS) and objective response rate (ORR), in patients with untreated extensive-stage small cell lung cancer (ES-SCLC), …

    Source: Cancer Network - New Jersey - Pending
  • Published on 21:11 GMT

    Survival Disparities Increase for Cancer Patients Without Health Insurance

    In a new study led by the American Cancer Society (ACS), researchers found that the introduction of immune checkpoint inhibitors (ICIs) following FDA approval was associated with a widening survival disparity between people without health insurance and …

    Source: Cancer Health - Pending
  • Published on 18:18 GMT

    Health service bureaucracy 'costing lives' of cancer patients - oncologist

    Health service bureaucracy is costing cancer patients’ lives, one of Ireland’s leading oncologists has warned.  Today, the Irish Cancer Society released a report detailing huge variations in access to life-saving cancer treatments across the country.  The …

    Source: Newstalk - Pending
  • Published on 12:44 GMT

    Vet Says 'Worst Call You Can Get' Is About Cats With One Key Symptom

    A viral TikTok video has sparked concern among cat owners after a veterinarian revealed what he calls the "worst call you can get" as a vet. In the video shared on Thursday, the poster @amirthevet says that, as a veterinarian, there is nothing …

    Source: Newsweek - Left-wing
  • Published on 19:40 GMT

    Industrial pollutant exposure stunts adolescents’ lung growth

    In India’s expanding industrial towns where development is often measured by the rising number of factories and manufacturing units, a silent health crisis is developing, one that particularly threatens the lungs of adolescents growing up in this polluted …

    Source: The Statesman (India) - Center-left
  • Published on Jul 7, 2025

    Sunvozertinib Approved by FDA as Oral Treatment of NSCLC With EGFR Exon 20 Insertion Mutations

    The FDA has granted accelerated approval to sunvozertinib (Zegfrovy; Dizal), an irreversible epidermal growth factor receptor (EGFR) inhibitor, for the treatment of adult patients with locally advanced or metastatic non-small cell lung cancer (NSCLC) with …

    Source: Pharmacy Times - Neutral
  • Published on 10:44 GMT

    The world economy is in need of disruptions 

    While many nations struggle under debt and flawed policies, Argentina’s recent reforms show that practical market solutions can deliver real economic recovery. Javier Milei’s policies could provide a global solution, but stubborn ideologists dismiss their …

    Source: Geopolitical Intelligence Services - Neutral

05 days 06:35:29

Featured Releases

Got News to Share? · Submit · See All
Got news to share? Submit it now.
Load more pharmaceuticals news or search news using your own keywords. There are 829,905,557 articles in our news database.

Online News Monitoring Made Simple

Established in 1995, EIN Newsdesk helps millions of users track breaking news across thousands of trusted websites. Users may set up custom email newsletters and RSS feeds or search among thousands of preset news sections. As a member, you may also submit your own news using the EIN Presswire distribution service. Membership is free and we do not sell or lease any information about you. Press release distribution, dedicated APIs, and custom services generate the revenue that allow us to offer you free basic access.

News by Country & by Industry

Worldwide News Coverage

Track news across more than 5,000 sources by country or industry or search our real-time news index.

Pharmaceutical Industry News by Country >
Pharmaceutical Industry News by U.S. State >
Pharmaceutical Industry News Topics >
Online News Publications >
World News Report >

News Alerts & News Feeds

Custom News Monitoring

News page results can be outputted as RSS or received daily by email. You may also use our NewsPlugin for WordPress.

Create Email Newsletter >
Create RSS Feed >
NewsPlugin for WordPress >

Submit News

PR Distribution Service

Our EIN Presswire's distribution footprint reaches millions. You can upload news which is re-published through EIN Newsdesk, fed into Twitter and Facebook, and onto partner sites, Google News, Bing News, etc.

EIN Presswire >
Events >

World Media Directory

News Media Guide

This is a listing of the world’s TV stations, radio stations, newspapers, and blogs. Last update: 06/17/2025

World Media Directory >

Healthcare & Pharmaceuticals Industry Press Releases

Got News to Share? · Submit · See All
Got news to share? Submit it now.

Healthcare & Pharmaceuticals Events

See All

No event was found.

Become a Member - Join Today!
Join thousands of professionals. Stay current. Stay competitive.
  • Track news from thousands of sources
  • Submit news sources for inclusion in our news tracking algorithm
  • Build your own customized email newsletters
  • Use of our RSS Feeds
  • Includes a complimentary EIN Presswire account plus 1-free release
  • Uncluttered & advertising free news pages

Pharmaceutical Industry Today by EIN Newsdesk & EIN Presswire (a press release distribution service)

Follow us on Facebook and connect with us on LinkedIn

Newsmatics Inc., 1025 Connecticut Avenue NW, Suite 1000, Washington, DC 20036 · Contact · About

© 1995-2025 Newsmatics Inc., a publisher of EIN News · All Rights Reserved · Privacy Policy · User Agreement